Nanjing Medlander Medical Technology Co.,Ltd. (SHA:688273)

China flag China · Delayed Price · Currency is CNY
44.29
+0.81 (1.86%)
Mar 9, 2026, 4:00 PM EDT
71.40%
Market Cap 4.33B
Revenue (ttm) 431.59M
Net Income (ttm) 102.06M
Shares Out 97.81M
EPS (ttm) 1.04
PE Ratio 42.45
Forward PE n/a
Dividend 0.60 (1.38%)
Ex-Dividend Date Nov 27, 2025
Volume 2,351,690
Average Volume 1,617,962
Open 42.56
Previous Close 43.48
Day's Range 41.55 - 44.53
52-Week Range 23.25 - 61.22
Beta 0.05
RSI 50.52
Earnings Date Apr 16, 2026

About SHA:688273

Nanjing Medlander Medical Technology Co.,Ltd. engages in the research and development, manufacture, sale, and service of pelvic floor rehabilitation equipment and related products in China and internationally. It offers pelvic floor and obstetrics and gynecology rehabilitation, reproductive rehabilitation product, and sports rehabilitation products, as well as consumables products, such as vaginal electrodes, rectal electrodes, vaginal probes, etc. The company also provides pelvic floor muscle rehabilitation, biological feedback and stimulation... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2013
Employees 566
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688273
Full Company Profile

Financial Performance

In 2025, SHA:688273's revenue was 431.59 million, an increase of 1.66% compared to the previous year's 424.55 million. Earnings were 102.06 million, an increase of 0.47%.

Financial Statements

News

There is no news available yet.